Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 601 | 570 | 275 | 900 | 625 |
| Cost of Goods | N/A | N/A | N/A | N/A | 2 |
| Gross Profit | 601 | 570 | 275 | 900 | 623 |
| Operating Expenses | 19,336 | 23,455 | 20,181 | 23,390 | 28,956 |
| Operating Income | -18,735 | -22,885 | -19,906 | -22,490 | -28,331 |
| Interest Expense | 2 | 1 | 2 | 809 | 489 |
| Other Income | 103 | 2,635 | 93 | 919 | -31 |
| Pre-tax Income | -18,634 | -20,251 | -19,815 | -22,380 | -28,851 |
| Net Income Continuous | -18,634 | -20,251 | -19,815 | -22,380 | -28,851 |
| Net Income | $-18,634 | $-20,251 | $-19,815 | $-22,380 | $-28,851 |
| EPS Basic Total Ops | -8.88 | -43.68 | -98.05 | -163.78 | -323.37 |
| EPS Basic Continuous Ops | -8.88 | -43.64 | -98.09 | -162.89 | -322.46 |
| EPS Diluted Total Ops | -8.88 | -43.68 | -98.05 | -163.78 | -323.37 |
| EPS Diluted Continuous Ops | -8.88 | -43.64 | -98.09 | -162.89 | -322.46 |
| EPS Diluted Before Non-Recurring Items | N/A | -43.68 | -98.69 | -163.78 | N/A |
| EBITDA(a) | $-18,641 | $-22,766 | $-19,699 | $-22,321 | $-28,024 |